Effects of Cornelian Cherry Supplementation in Patients With Metabolic Syndrome | MicrobiomeTrials← Back to trialsNCT07739602
Effects of Cornelian Cherry Supplementation in Patients With Metabolic Syndrome
CompletedNAINTERVENTIONAL
Trial Details
Start: 2019-01-17Est. Completion: 2026-06-25
Enrollment target: 55 participants Locations- Department of Pharmacology, Wroclaw Medical University, Wroclaw, Poland
Other microbiome trials you might be interested in
Overweight and Obese Adults
Obesity is a complex disease and a major risk factor for cardiovascular and metabolic disorders, particularly atheroscle…
Istanbul, Turkey (Türkiye)Est. completion Sep 30, 2026
Lymphohistiocytosis, HemophagocyticSecondary Hemophagocytic LymphohistiocytosisMacrophage Activation SyndromeHyperinflammatory Syndromes
Background:
Hemophagocytic lymphohistiocytosis (HLH) is a disease caused by disrupted immune function. People with HLH …
Bethesda, United StatesEst. completion Oct 1, 2030
Erythropoietic Protoporphyria
This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in pa…
Birmingham, United StatesCompleted Jun 2028